🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of vedoliz...
Status
Completed
Location
IMC - Diagnostic and Medical Clinic
Start Date
2015-06-29
Trial ID
NCT02497469
Treatments Being Tested
Reduction of signs and symptoms in patients with moderate to severely early...
Status
Unknown
Location
Charité Campus Benjamin Franklin, Rheumatology
Start Date
2005-03
Trial ID
NCT00235105
Treatments Being Tested
To evaluate the safety profile, the effectiveness and the economic impact o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00513370
Treatments Being Tested
The purpose of this study was to investigate the efficacy, safety, and phar...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-28
Trial ID
NCT02533375
Treatments Being Tested
In a randomized controlled clinical trial, investigators will compare the e...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-07
Trial ID
NCT02374021
Treatments Being Tested
Safety and Efficacy study of AVT02 (Alvotech Biosimilar to Adalimumab), in ...
Status
Completed
Location
Innomedica OU
Start Date
2019-02-20
Trial ID
NCT03849404
Treatments Being Tested
The purpose of this study is to obtain increased knowledge concerning centr...
Status
Completed
Location
Dep of Rheumatology
Start Date
2010-10
Trial ID
NCT01197144
Treatments Being Tested
W11-050 is a Mexican open label multicenter study that has been designed to...
Status
Completed
Location
Site Reference ID/Investigator# 50942
Start Date
2010-10
Trial ID
NCT01265823
Treatments Being Tested
To evaluate efficacy, safety and pharmacokinetics of adalimumab in Japanese...
Status
Completed
Location
Site Reference # / Investigator 46791
Start Date
2008-02
Trial ID
NCT00667355
Treatments Being Tested
This is a multicenter, Phase 3 randomized, placebo-controlled study designe...
Status
Completed
Location
Site Ref # / Investigator 45524
Start Date
2002-09
Trial ID
NCT00048542